Aytu Biopharma, Inc. (AYTU)
2.56
-0.01
(-0.39%)
USD |
NASDAQ |
May 06, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Shareholders Equity (Quarterly) : 14.20M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Illumina, Inc. | 2.676B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -271.11M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Total Liabilities (Quarterly) | 107.80M |
| Debt to Equity Ratio | 1.556 |
| Current Ratio | 1.163 |
| Net Debt Paydown Yield | -2.81% |